1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
- 2007
-
Mark
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma
(
- Contribution to journal › Article
- 2001
-
Mark
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler
(
- Contribution to journal › Article
-
Mark
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study
(
- Contribution to journal › Article
-
Mark
Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group
(
- Contribution to journal › Article
- 1999
-
Mark
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
(
- Contribution to journal › Article
- 1994
-
Mark
Treatment with cyclosporin A during sensitization with trimellitic anhydride attenuates the airway responses to allergen challenge three weeks later
(
- Contribution to journal › Article
- 1993
-
Mark
Bradykinin-induced airflow obstruction and airway plasma exudation: effects of drugs that inhibit acetylcholine, thromboxane A2 or leukotrienes
(
- Contribution to journal › Article
-
Mark
Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor
(
- Contribution to journal › Article